Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes The Phase 1 trial will assess the ...
A ballistic missile has struck energy infrastructure supposedly covered by the "energy ceasefire" announced by Trump on Sunday, Zelenskyy said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results